Phase 1 oncology trials and informed consent
- PMID: 23161617
- DOI: 10.1136/medethics-2012-100832
Phase 1 oncology trials and informed consent
Abstract
Ethical concerns have been raised about the quality of informed consent by participants in phase 1 oncology trials. Interview surveys indicate that substantial proportions of trial participants do not understand the purpose of these trials-evaluating toxicity and dosing for subsequent efficacy studies-and overestimate the prospect of therapeutic benefit that they offer. In this article we argue that although these data suggest the desirability of enhancing the process of information disclosure and assessment of comprehension of the implications of study participation, they do not necessarily invalidate consent by phase 1 trial participants.
Keywords: Informed Consent.
Similar articles
-
Therapeutic misconception in early phase gene transfer trials.Soc Sci Med. 2006 Jan;62(1):239-53. doi: 10.1016/j.socscimed.2005.05.022. Epub 2005 Jul 5. Soc Sci Med. 2006. PMID: 16000230
-
Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?Clin Trials. 2008;5(6):617-23. doi: 10.1177/1740774508097576. Clin Trials. 2008. PMID: 19029210
-
Study of cohort-specific consent and patient control in phase I cancer trials.J Clin Oncol. 1998 Jul;16(7):2305-12. doi: 10.1200/JCO.1998.16.7.2305. J Clin Oncol. 1998. PMID: 9667244 Clinical Trial.
-
Conflict of interest and informed consent in industry-sponsored clinical trials.J Leg Med. 1991 Dec;12(4):477-513. doi: 10.1080/01947649109510865. J Leg Med. 1991. PMID: 1800586 Review. No abstract available.
-
Improvement of informed consent and the quality of consent documents.Lancet Oncol. 2008 May;9(5):485-93. doi: 10.1016/S1470-2045(08)70128-1. Lancet Oncol. 2008. PMID: 18452859 Review.
Cited by
-
Phase I trials as valid therapeutic options for patients with cancer.Nat Rev Clin Oncol. 2019 Dec;16(12):773-778. doi: 10.1038/s41571-019-0262-9. Epub 2019 Sep 2. Nat Rev Clin Oncol. 2019. PMID: 31477881 Free PMC article. Review.
-
Decision-making and autonomy among participants in early-phase cancer immunotherapy trials: a qualitative study.BMC Cancer. 2024 Mar 25;24(1):373. doi: 10.1186/s12885-024-12119-7. BMC Cancer. 2024. PMID: 38528488 Free PMC article.
-
Participants' understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis.Bull World Health Organ. 2015 Mar 1;93(3):186-98H. doi: 10.2471/BLT.14.141390. Epub 2015 Jan 22. Bull World Health Organ. 2015. PMID: 25883410 Free PMC article.
-
"It is not guaranteed that you will benefit": True but misleading?Clin Trials. 2015 Aug;12(4):424-9. doi: 10.1177/1740774515585120. Epub 2015 May 11. Clin Trials. 2015. PMID: 25963311 Free PMC article. Clinical Trial.
-
Variations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials.J Empir Res Hum Res Ethics. 2017 Oct;12(4):280-288. doi: 10.1177/1556264617720433. Epub 2017 Jul 21. J Empir Res Hum Res Ethics. 2017. PMID: 28728498 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical